Patrick Sartore

Patrick was appointed as President, effective November 13, 2020. Prior to that, he was one of two Chief Operating Officers. In this role, Patrick was responsible for the company’s commercial, marketing, clinical development, manufacturing, and corporate & business development functions, related to Plasma-Derived Therapeutics. A lawyer by training, he has spent over 18 years working in the life sciences and pharmaceutical industry. He has more than fourteen years of experience with Liminal and has held a number of senior global positions across the organization.